Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Research Article Volume 6 Issue 12

Role of LDH in Predicating the Severity and Mortality in COVID-19 Patients in Comparison to Other Laboratory Markers at the Time of Admission

Nidhi Ranawat1*, Shreshtha Tiwari2, Animesh Choudhary3, Sandeep Ojha4, Shishir Agarwal5, Ashish Mazumdar6 and Jayesh Sharma7

1Clinical Biochemist, Department of Laboratory Medicine, BALCO Medical Centre, Raipur (Chhattisgarh), India
2Consultant, Microbiology and Infection Control Officer, Department of Laboratory Medicine, BALCO Medical Centre, Raipur (Chhattisgarh), India
3Associate Professor, Raipur Institute of Medical Sciences, Raipur (Chhattisgarh), India
4Consultant and Head Pathology, Department of Laboratory Medicine, BALCO Medical Centre, Raipur (Chhattisgarh), India
5Junior Consultant, Radiology, BALCO Medical Centre, Raipur (Chhattisgarh), India
6Senior Consultant and Head of Department, Anaesthesiology, Critical care Pain and Palliative Care, BALCO Medical Centre, Raipur (Chhattisgarh), India
7Chief of Medical Services, Sr. Consultant, Surgical Oncology, Department of Surgical Oncology, BALCO Medical Centre, Raipur (Chhattisgarh), India

*Corresponding Author: Nidhi Ranawat, Clinical Biochemist, Department of Laboratory Medicine, BALCO Medical Centre, Raipur (Chhattisgarh), India.

Received: November 01, 2022; Published: November 15, 2022


Objectives: To correlate Serum LDH levels with severity of COVID 19, and establish LDH as potential marker for COVID 19 prognosis and treatment.

Materials and Method: The study is performed in 204 confirmed COVID 19 cases at a dedicated COVID care Hospital. Lab investigations including Serum LDH, Ferritin, CRP, and D-dimer were estimated at the time of patient admission. The patients were divided into 2 groups namely severe and non-severe based on WHO guidelines. The values for these parameters were compared and the sensitivity and specificity of every parameter was analysed concerning COVID-19 severity and mortality.

Statistical Analysis: Unpaired t-test was used for statistics between the severe and non-severe groups followed by ROC analysis for LDH, CRP, Ferritin, and D-dimer.

Results: The levels of LDH, CRP, and D-dimer were raised in the patients in the severe group as compared to the non-severe group with a significant p-value of < 0.05. Also in ROC analysis the sensitivity and specificity of LDH were found to be good for CRP, Ferritin, and D-dimer. Also, it was observed that among 204 patients, 29 patients died due to COVID, and their serum LDH values were found to be increased which was not the case in the other 3 parameters.

Conclusions: LDH was a better marker in predicting the Severity of COVID-19 disease, also its value is highly significant in predicting the mortality of patients at the time of admission which can help in early prognosis and help in the clinical management of the patient.

Keywords: LDH; COVID 19; Severity


  1. Wu My., et al. “Clinical evaluation of potential usefulness of serum lactate dehydrogenase (LDH) in 2019 novel coronavirus (COVID-19) pneumonia”. Respiratory Research 21 (2020): 171.
  2. Li C., et al. “Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19”. Aging (Albany NY)15 (2020): 15670-15681.
  3. WHO COVID-19 Dashboard.
  4. CDC website: “Symptoms for COVID-19”.
  5. Francone M., et al. “Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis”. European Radiology12 (2020): 6808-6817.
  6. Das B., et al. “Evaluation of the Role of Routine Laboratory Biomarkers in COVID-19 Patients: Perspective from a Tertiary Care Hospital in India”. Indian Journal of Clinical Biochemistry 4 (2021): 473-484.
  7. Henry BM., et al. “Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis”. American Journal of Emergency Medicine 9 (2020): 1722-1726.
  8. “Clinical management of COVID-19: interim guidance, 27 May 2020": WHO/2019-Nov/clinical/2021.1 (2020).
  9. Fu L., et al. “Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis”. Journal of Infection6 (2020): 656-665.
  10. Gao Y., et al. “Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19”. Journal of Medical Virology7 (2020): 791-796.


Citation: Nidhi Ranawat., et al. “Role of LDH in Predicating the Severity and Mortality in COVID-19 Patients in Comparison to Other Laboratory Markers at the Time of Admission". Acta Scientific Pharmaceutical Sciences 6.12 (2022): 20-24.


Copyright: © 2022 Nidhi Ranawat., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate32%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US